Label: SUNSCREEN GLOWING, SPF 30- sunscreen glowing lotion lotion
- NDC Code(s): 70000-0280-1
- Packager: Cardinal Health, Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 10, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- active ingredient
- purpose
- WARNINGS
- STOP USE
- DO NOT USE
- KEEP OUT OF REACH OF CHILDREN
-
INDICATIONS & USAGE
Directions
Apply liberally 15 minutes before sun exposure. Reapply: at least every 2 hours or after
80 minutes of swimming or sweating. Sun Protection Measures: $pending time in the
sun increases your risk of skin cancer andearly skin aging. To decrease this risk,
regularly use a sunscreen with a Broad Spectrum SPfof 15 or higher and other sun
protection measures including: limit time in the sun, especiallyfrom 10 a.m.-2 pm, and
wear long-sleeved shirts, pants, hats, and sunglasses. Childrenunder 6 months of age
ask a doctor.
- DOSAGE & ADMINISTRATION
- WHEN USING
-
INACTIVE INGREDIENT
WATER
BUTYLOCTYL SALICYLATE
NEOPENTYL GLYCOL DIHEPTANOATE
MICA
CI 77891
BUTYL METHOXYDIBENZOYLMETHANE
GLYCERIN
PROPYLENE GLYCOL
VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER
CETEARYL ALCOHOL
COCO-GLUCOSIDE
GLYCERYL STEARATE
PEG-100 STEARATE
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER
SILICA
POTASSIUM CETYL PHOSPHATE
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
CETEARYL ALCOHOL
HYDROXYACETOPHENONE
PHENOXYETHANOL
ETHYLHEXYLGLYCERIN
CI 77492
TRIETHOXYCAPRYLYLSILANE
DISODIUM EDTA
CI 77491
CI 77499 - PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
SUNSCREEN GLOWING, SPF 30
sunscreen glowing lotion lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:70000-0280 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 4.5 g in 50 mL OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 3.5 g in 50 mL AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 1.5 g in 50 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 2.5 g in 50 mL Inactive Ingredients Ingredient Name Strength PEG-100 STEARATE (UNII: YD01N1999R) BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3) PHENOXYETHANOL (UNII: HIE492ZZ3T) TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E) EDETATE DISODIUM (UNII: 7FLD91C86K) AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG) CETEARYL ALCOHOL (UNII: 2DMT128M1S) CI 77499 (UNII: XM0M87F357) COCO GLUCOSIDE (UNII: ICS790225B) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (HARD PARTICLE) (UNII: H895X08VNQ) CI 77491 (UNII: 1K09F3G675) HYDROXYACETOPHENONE (UNII: G1L3HT4CMH) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) MICA (UNII: V8A1AW0880) CI 77891 (UNII: 15FIX9V2JP) CI 77492 (UNII: EX438O2MRT) GLYCERYL STEARATE (UNII: 230OU9XXE4) POTASSIUM CETYL PHOSPHATE (UNII: 03KCY6P7UT) GLYCERIN (UNII: PDC6A3C0OX) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) SILICA (UNII: ETJ7Z6XBU4) NEOPENTYL GLYCOL DIHEPTANOATE (UNII: 5LKW3C543X) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70000-0280-1 50 mL in 1 BOTTLE; Type 0: Not a Combination Product 12/14/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 12/14/2024 Labeler - Cardinal Health, Inc (063997360)